Given these controversies among our previous results and what was already known, the objective of the present work is to determine the proteins and the potential molecular mechanisms that could establish a link between the activity of RUNX1 and NAFLD pathogenesis by means of systems biology. The gene discussed is RUNX1; the disease is metabolic dysfunction-associated steatotic liver disease.